Condition
Methamphetamine Addiction
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 1 (2)
P 2 (2)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07319325Not ApplicableCompletedPrimary
Efficacy of Adaptive, Gamified Digital Therapeutics Intervention for Individuals With Methamphetamine Use Disorder in Community Rehabilitation
NCT00713479Phase 1CompletedPrimary
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
NCT00506935Phase 1CompletedPrimary
Assessment of GVG for the Treatment of Methamphetamine Dependence
NCT00538655Phase 2CompletedPrimary
A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence
NCT00630682Phase 2CompletedPrimary
A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
Showing all 5 trials